IRB Barcelona is to participate in the second edition of the Barcelona International Youth Science Challenge (BIYSC), organised by the
Today sees the start of the three-day international partnering conference BIO-Europe Spring 2017, with
On 17 and 18 March, fifteen secondary school teachers from around Catalonia will have the opportunity to learn about the fruit fly Drosophila melanogaster, an animal model used to study de
The European Research Council (ERC) is celebrating its 10th anniversary.
On the occasion of the BIO-Europe Spring 2017 event in Barcelona, the newspaper “La Vanguardia” has published an article about the campaign to host the new headquarters of the London-based European Medicines Agency (EMA) after Brexit.
European Biotechnology magazine
The 2017 Issue of the European Biotechnology magazine on the Life Sciences and Industry features recent studies conducted at IRB Barcelona by Oriol Gallego, research associate with the Translational Control of Cell Cycle and Differentiation Lab, and Salvador Aznar Benitah, ICREA researcher and group leader of the Stem Cells and Cancer Lab.
Diari de Girona
The local newspaper “Diari de Girona” publishes an article about the discovery of a mechanism responsible for halting protein synthesis when cells are deprived of nutrients. This discovery has been made by researchers at the Consejo Superior de Investigaciones Científicas (CSIC) in Madrid and Salamanca and at IRB Barcelona.
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Felice Alessio Bava
former PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Quick facts about IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.